EUSA Pharma (Denmark) ApS: Financial statements 2020
CVR: 39055988
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
EUSA Pharma (Denmark) ApS (CVR 39055988) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 9,829,410 and a net result of DKK 607,118 compared with DKK 228,408 the year before. That is an increase of 377.4% compared with the year before. Equity in the 2020 report amounted to DKK 822,576. The solvency ratio was 27.8%. The company had 6 employees in the financial year.
- Gross Profit
- DKK 9,829,410
- Profit/Loss
- DKK 607,118
- Equity
- DKK 822,576
- Total Assets
- DKK 2,956,167
- Employees
- 6
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | 9.8 mio. | 607 t. | 823 t. | 6 |
| 2019 | - | 2.1 mio. | 228 t. | 215 t. | 3 |
How creditworthy is EUSA Pharma (Denmark) ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
EUSA Pharma (Denmark) ApS has published its annual report for 2019. Gross profit came to DKK 2,058,784, and the net result was DKK 228,408.
About EUSA Pharma (Denmark) ApS
EUSA Pharma (Denmark) ApS was a Danish company of the type Anpartsselskab based in Hellerup, founded in 2017. The company has been dissolved on 19 December 2024. The company was registered under the industry Reklamebureauer. According to the 2023 annual report, the company had an average of 1 employee. In 2023, the company reported a gross profit of DKK 1,928,889 and a net result of DKK 141,012 compared with DKK 198,473 the year before. Equity in the 2023 report amounted to DKK 1,644,740.